DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Pemmaraju N, Kantarjian H, Nastoupil L. et al.
Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy.
Blood 2019;
133: 2348-2351
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.